Gainers
- Ambrx Biopharma AMAM shares increased by 9.3% to $0.57 during Monday's after-market session. This security traded at a volume of 56.3K shares come close, making up 186.4% of its average volume over the last 100 days. The market value of their outstanding shares is at $21.9 million.
- Bone Biologics BBLG stock moved upwards by 6.56% to $0.29. The company's market cap stands at $4.4 million.
- Predictive Oncology POAI stock moved upwards by 6.31% to $0.54. Predictive Oncology's trading volume hit 67.8K shares by close, accounting for 21.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $42.1 million.
- SCWorx WORX shares moved upwards by 5.03% to $0.7. The company's market cap stands at $9.0 million.
- AquaBounty Technologies AQB shares rose 4.96% to $0.7. The company's market cap stands at $49.7 million.
- Hepion Pharmaceuticals HEPA stock moved upwards by 4.95% to $0.4. Trading volume for this security closed at 67.2K, accounting for 36.2% of its average full-day volume over the last 100 days. The company's market cap stands at $30.4 million.
Losers
- Milestone Pharmaceuticals MIST stock decreased by 9.5% to $4.3 during Monday's after-market session. The company's market cap stands at $147.4 million.
- UpHealth UPH stock decreased by 8.82% to $0.3. The company's market cap stands at $45.1 million.
- TherapeuticsMD TXMD shares decreased by 7.82% to $4.72. At the close, TherapeuticsMD's trading volume reached 645.5K shares. This is 916.4% of its average volume over the last 100 days. The company's market cap stands at $44.6 million.
- Jounce Therapeutics JNCE shares fell 5.0% to $0.86. The market value of their outstanding shares is at $44.5 million.
- Bright Green BGXX shares decreased by 5.0% to $0.58. The company's market cap stands at $98.9 million.
- Intelligent Bio Solutions INBS stock fell 4.99% to $0.31. The company's market cap stands at $5.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in